---
title: "Hansen Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 11.2572 million yuan, a year-on-year decrease of 80.68%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237593498.md"
description: "According to the Zhitong Finance APP, Hansen Pharmaceutical released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 269 million yuan, a year-on-year increase of 6.00%. The net profit attributable to shareholders of the listed company was 11.2572 million yuan, a year-on-year decrease of 80.68%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 9.1164 million yuan, a year-on-year decrease of 83.49%"
datetime: "2025-04-25T14:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237593498.md)
  - [en](https://longbridge.com/en/news/237593498.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237593498.md)
generator: "portal-rs"
---

# Hansen Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 11.2572 million yuan, a year-on-year decrease of 80.68%

According to the Zhitong Finance APP, Hansen Pharmaceutical (002412.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 269 million yuan, a year-on-year increase of 6.00%. The net profit attributable to shareholders of the listed company was 11.2572 million yuan, a year-on-year decrease of 80.68%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 9.1164 million yuan, a year-on-year decrease of 83.49%

### Related Stocks

- [002412.CN](https://longbridge.com/en/quote/002412.CN.md)

## Related News & Research

- [Alpha Entrepreneurial Partners Investment TGV takes 3.03% stake in q.beyond voting rights](https://longbridge.com/en/news/296450706.md)
- [23:31 ETWACO Corp. Unveils Redesigned 'ATLAS' Smart Public Water Refill Station Following Successful Tokyo PoC](https://longbridge.com/en/news/296430029.md)
- [Rein Therapeutics releases corporate presentation on LTI-03 idiopathic pulmonary fibrosis program](https://longbridge.com/en/news/296389731.md)
- [Upside Gold exceeds 4,000-meter drill plan at Kena gold-copper project](https://longbridge.com/en/news/296356118.md)
- [Precision Peptide develops needle-free tirzepatide transdermal patch in U.S](https://longbridge.com/en/news/296344248.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**